Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy

被引：0
|
作者：
Min Soo Kim
Nayoung Kim
Sung Eun Kim
Hyun Jin Jo
Cheol Min Shin
Young Soo Park
Dong Ho Lee
机构：
[1] Seoul National University Bundang Hospital,Department of Internal Medicine
[2] Seoul National University College of Medicine,Department of Internal Medicine and Liver Research Institute
来源：
BMC Gastroenterology | / 13卷
关键词：
Reinfection; Quadruple; Moxifloxacin; Second-line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy
    Kim, Min Soo
    Kim, Nayoung
    Kim, Sung Eun
    Jo, Hyun Jin
    Shin, Cheol Min
    Park, Young Soo
    Lee, Dong Ho
    BMC GASTROENTEROLOGY, 2013, 13
  • [2] Long-Term Follow up Helicobacter pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy
    Kim, Nayoung
    Kim, Min Soo
    Nam, Ryoung Hee
    Choi, Mi Ji
    Jo, Hyun Jin
    Shin, Cheol Min
    Lee, Dong Ho
    GASTROENTEROLOGY, 2013, 144 (05) : S335 - S335
  • [3] Moxifloxacin-Containing Triple Therapy versus Bismuth-Containing Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis
    Wu, Cheng
    Chen, Xiao
    Liu, Jing
    Li, Ming-Yang
    Zhang, Zi-Qi
    Wang, Zhi-Qiang
    HELICOBACTER, 2011, 16 (02) : 131 - 138
  • [4] Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea
    Cheon, Jae Hee
    Kim, Nayoung
    Lee, Dong Ho
    Kim, Jung Mogg
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (05) : 515 - 519
  • [5] Efficacy of Second-Line Treatment for Helicobacter pylori Infection: Moxifloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy
    Chung, Kwang Hyun
    Lee, Dong Ho
    Kim, Nayoung
    Shin, Cheol Min
    Hwang, Jin Hyeok
    Lee, Sang Hyub
    Lee, Donghyeon
    Oh, Hong Sang
    Jin, Eun Hyo
    GASTROENTEROLOGY, 2012, 142 (05) : S483 - S484
  • [6] Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection
    Cheon, JH
    Kim, N
    Lee, DH
    Kim, JM
    Kim, JS
    Jung, HC
    Song, IS
    HELICOBACTER, 2006, 11 (01) : 46 - 51
  • [7] META-ANALYSIS OF LEVOFLOXACIN-CONTAINING TRIPLE THERAPY VERSUS BISMUTH-CONTAINING QUADRUPLE THERAPY AS SECOND-LINE TREATMENT IN THE ERADICATION OF HELICOBACTER PYLORI
    Marin, A. C.
    McNicholl, A. G.
    Gisbert, J. P.
    HELICOBACTER, 2011, 16 : 132 - 132
  • [8] Second-line treatment for Helicobacter pylori infection:: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy
    Kang, Jung Mook
    Kim, Nayoung
    Lee, Dong Ho
    Park, Young Soo
    Kim, Yu Rim
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    HELICOBACTER, 2007, 12 (06) : 623 - 628
  • [9] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Sung Eun Kim
    Moo In Park
    Seun Ja Park
    Won Moon
    Jae Hyun Kim
    Kyoungwon Jung
    Hae Koo Kim
    Young Dal Lee
    World Journal of Gastroenterology, 2017, (06) : 1059 - 1066
  • [10] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Kim, Hae Koo
    Dal Lee, Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (06) : 1059 - 1066
12345